André Farias | BrazMedChem 2019 | Galoá Proceedings

André Farias

Is this your profile? Do login to access your certificates

IDENTIFICATION OF BRAZILIAN BIODIVERSITY PRODUCTS AND APPROVED DRUGS AS POTENTIAL ANTI-INFLAMMATORY AGENTS, IRAK-1 AND IRAK-4 INHIBITORS
Stephany Torres
André Farias
Nelilma Correia Romeiro
Vol. 1, 2019 -
115619

1. Strategies in Drug Design

Poster only

Co-authors (2)

Publications in other proceedings

Event
Indole-N-acylhydrazones derivatives as multitarget-directed ligands: potential of privileged scaffolds for Alzheimer’s disease treatment.